國家發展奈米醫學之人體風險治理核心規範初探——以國際風險治理委員會（IRGC）之架構為借鏡

Preliminary Study of Human Risk Regulation on the National development of Nano-medicine–Taking Reference of IRGC

奈米科技為人類 21 世紀最重要科技之一，其運用範圍廣泛從化妝品、清潔塗料等民生用品，到積體電路、癌症治療等尖端科技均可見其身影，未來發展及潛在商機難以估量。然而，人類對於奈米技術的研究仍在起步階段，對於其潛在風險的認識更是少之又少。由於許多數據資料顯示奈米物質對於自然環境已造成一定的影響，除應積極正視奈米風險的問題，從新興科技之產業經濟面及人類環境保護風險預防面的角度，政府在政策上應與產業界積極合作發展奈米科技之風險治理架構。本文認為政府可參考國際風險治理委員會（The International Risk Governance Council, IRGC）奈米風險治理架構，對於奈米科技風險採取分類控管的原則，作為評估上的輔助原則，訂定一套能與時俱進，靈活彈性的國家奈米科技風險治理方針，以兼顧以求環境與產業之最大利益。

Nanotechnology has been regarded as one of most significant technologies in the 21st century. Nanotechnology could be broadly applied in the fields from daily used products such as cosmetics, clean material to the high technologies like semiconductor and cancer treatment and other emerging industries so that its commercial potentiality is unevaluated. However, since nanotechnology is still at its initial stage its application research, we have do not have a comprehensive understanding of its potential risks. Hence, from perspectives of industrial economic dimension and protection of human environment, it is essential for government to collaborate with related industries on these issues. This paper argued that government take precaution measures on nanotechnology risks set by IRGC. There are numerous evidences shown that nanotechnology has resulted in environmental effects. It is submitted that government should recognize these issues by taking reference of IRGC rule when making governmental policy on the development of nanotechnology industry.